| Literature DB >> 26887657 |
Jin Lu1, Jian Hou2, Kai-Yan Liu1, Simrit Parmar3, Adolfo De La Fuente4, Börje Andersson3, ChenHua Yan1, Daobin Zhou5, Daryl Tan6, David Ritchie7, Deipei Wu8, Elizabeth Shpall3, Ginna G Laport9, JianYong Li10, Jiong Hu11, Lian Sheng Zhang12, Michael Wang3, Pankaj Malhotra13, Qian Jiang1, Yazhen Qin1, Raymond Wong14, Richard Champlin3, Surapol Issaragrisil15, Swaminathan Iyer16, Vikram Mathews17, Yu Wang1, Yu Hu18, Zhijian Xiao19, Zonghong Shao20, Rafael Rosengarten21,22, Jon Steuernagle22,23, Jun Huang Xiao1, Robert Orlowski3, Chor Sang Chim24.
Abstract
The Asia-Pacific Hematology Consortium (APHCON), in partnership with MDRingTM, a mobile global physician education network, has initiated a detailed longitudinal study of physician knowledge and practice preferences in the Asia-Pacific sphere. The first dataset comes from a series of surveys answered by delegates at the APHCON Bridging The Gap (BTG) conference in Beijing in January, 2015. In this report we present our findings regarding diagnosis and treatment of multiple myeloma (MM). We aim to create a conduit for physicians in this region to share their experiences with the rest of the world, to identify areas of consensus and best practices, and to highlight opportunities for improvement in communication, education and patient care.Entities:
Keywords: APHCON; China; MDRing; Myeloma; survey
Mesh:
Year: 2016 PMID: 26887657 DOI: 10.3109/10428194.2015.1135434
Source DB: PubMed Journal: Leuk Lymphoma ISSN: 1026-8022